Vasant Narasimhan - Wikipedia Vasant " Vas " Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis [1][2][3][4] He succeeded Joseph Jimenez who left Novartis in 2018 [5]
Vasant Narasimhan | Novartis Vasant (Vas) Narasimhan, M D , has been Chief Executive Officer (CEO) of Novartis since February 1, 2018
Vasant Narasimhan | CEO of Novartis | Leader in Global Healthcare Vasant Narasimhan, CEO of Novartis, earns an annual salary of approximately ₹20 crore (about $21 million USD in 2024), with total compensation reaching around $28 million including bonuses and stock options
TIME100 Health: Vas Narasimhan In 2018, he became CEO of Novartis and seized the opportunity to direct the company’s vast resources for transformative change
HIGHLIGHTS: Vasant Narasimhan - CEO of Novartis | Norges Bank . . . Nicolai Tangen speaks with Vasant 'Vas' Narasimhan, CEO of Novartis, about pioneering pharmaceutical innovation They explore breakthrough cell and gene therapies, AI partnerships with leading tech companies, and how Novartis transformed from a sprawling conglomerate into a streamlined drug discovery company
Novartis CEO and Key Executive Team - Craft. co Novartis's Chief Executive Officer is Vasant Narasimhan Other executives include Kees Roks, Chief Audit Officer; Harry Kirsch, Chief Financial Officer and 21 others See the full leadership team at Craft
Davos 2026 | Novartis CEO Vas Narasimhan sees AI payoff for . . . - CNBCTV18 Novartis CEO Vas Narasimhan said the pharmaceutical sector is likely to see tangible benefits from artificial intelligence over the next seven to ten years, as companies deepen the use of advanced technologies across research, development and manufacturing
Executive Committee - Novartis Under the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations